"Nov. 26, 2014 -- Gift-buying season is here, and on top of the wish list for most people is the latest tech gadget or gizmo. But some experts are concerned that more tech may equal more pain for frequent users.
For starters, we take"...
Butrans Patient Information Including Side Effects
Brand Names: Butrans
Generic Name: buprenorphine (transdermal) (Pronunciation: BUE pre NOR feen)
- What is this drug (Butrans)?
- What are the possible side effects of this drug (Butrans)?
- What is the most important information I should know about this drug (Butrans)?
- What should I discuss with my health care provider before using this drug (Butrans)?
- How should I use this drug (Butrans)?
- What happens if I miss a dose (Butrans)?
- What happens if I overdose (Butrans)?
- What should I avoid while using this drug (Butrans)?
- What other drugs will affect this drug (Butrans)?
- Where can I get more information?
What is this drug (Butrans)?
Buprenorphine is an opioid pain medication. An opioid is sometimes called a narcotic.
Buprenorphine transdermal (skin patch) is used to treat moderate to severe chronic pain when treatment is needed around the clock.
Buprenorphine is not for treating pain just after surgery, or for treating occasional short-term pain.
Buprenorphine transdermal may also be used for purposes not listed in this medication guide.
What are the possible side effects of this drug (Butrans)?
Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Stop using buprenorphine and call your doctor at once if you have a serious side effect such as:
- slow heart rate, weak or shallow breathing, deep sighs, snoring that is new or unusual;
- confusion, severe dizziness, feeling like you might pass out;
- blisters, swelling, or severe irritation where the patch was worn;
- seizure (convulsions); or
- nausea, upper stomach pain, itching, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes).
Less serious side effects may include:
- vomiting, dry mouth, upset stomach, constipation;
- mild dizziness or drowsiness; or
- redness, itching, or mild skin rash where the patch was worn.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Read the Butrans (buprenorphine transdermal system) Side Effects Center for a complete guide to possible side effects
What is the most important information I should know about this drug (Butrans)?
You should not use buprenorphine if you are allergic to it, or if you have a severe breathing disorder such as asthma, or a bowel obstruction called paralytic ileus.
Never wear more than 1 buprenorphine skin patch at a time unless your doctor has told you to.
Do not expose the skin patch to heat while you are wearing it. Heat can increase the amount of drug you absorb through your skin and may cause harmful effects.
Call your doctor at once if you have weak or shallow breathing, snoring that is new or unusual, slow heart rate, confusion, severe dizziness, seizure, or feeling like you might pass out.
Avoid letting another person handle your buprenorphine skin patches. Keep both used and unused patches out of the reach of children or pets. The amount of buprenorphine in a used skin patch could be fatal to a child or pet who accidentally sucks or chews on it. Seek emergency medical attention if this happens.
Do not stop using buprenorphine suddenly, or you could have unpleasant withdrawal symptoms. Ask your doctor how to avoid withdrawal symptoms when you stop using buprenorphine.
Additional Butrans Information
Butrans - User Reviews
Butrans User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Chronic Pain/Back Pain
Find tips and advances in treatment.